Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Cell. Infect. Microbiol.

Sec. Microbes and Innate Immunity

Volume 15 - 2025 | doi: 10.3389/fcimb.2025.1553464

This article is part of the Research TopicRespiratory Pathogen Infection and Host Innate Immune ResponseView all 7 articles

Topic: Comparative temporal transcriptome analyses of SARS-CoV-2 Delta and Omicron variants ex-vivo infection in cat lung explant culture

Provisionally accepted
  • 1ICAR-National Institute of High Security Animal Diseases (ICAR-NIHSAD), Bhopal, India
  • 2National Bureau of Animal Genetic Resources (NBAGR), Karnal, Haryana, India
  • 3AASRA, Bhopal, India

The final, formatted version of the article will be published soon.

The rapid evolution of SARS-CoV-2 variants, have posed significant public health challenges due to their heightened transmissibility and varying clinical outcomes. While the impact of these variants in humans has been extensively studied, their effect on domestic animals has not been explored thoroughly. Given the close contact between humans and pets, combined with documented cases of virus transmission from humans to domestic animals and the potential for these animals to act as viral reservoirs, highlights the importance of understanding the molecular dynamics of SARS-CoV-2 infection in them. Consequently, there is an increasing demand for infection models that closely mimic viral behavior in animal tissues. In vivo infection of cats or any other non-laboratory animal species is extremely resource intensive, time consuming, require ABSL3 facilities, and animal ethical clearances which are not practically possible for the majority of researchers. In this scenario the ex vivo cultures model can be an excellent alternative. Therefore, in this study, we have utilized an ex vivo lung explant culture model derived from domestic cats to examine the host's response to Delta and Omicron variants of SARS-CoV-2 in cat lung explant culture. Comprehensive transcriptomic profiling at multiple time points post-infection revealed significant disruptions in genes associated with cell adhesion, structural components, extracellular matrix (ECM) organization and regulation, secreted and growth factors, and immune responses. Our study revealed that the Delta variant triggered early activation of genes associated with tissue damage as early as 12 hours post-infection (hpi). By 24 hpi, both the Delta and Omicron variants showed significant activation of these genes, with the Delta variant linked to the activation of a larger number of tissue damage-related genes. Notably, we identified several hub genes, including MMP9, CCL5, MCP-1/CCL2, VWF, HGF, ANGPT1, CD34, CD68, SPP1, IGF1, CSF1, and VCL, involved in critical signaling pathways such as focal adhesion, PI3K-Akt signaling, and TNF signaling. These hub genes hold potential as valuable biomarkers. This study provides key insights into the pathogenesis of SARS-CoV-2 in cats and highlights the utility of ex vivo lung explant cultures as a platform for studying viral infections.

Keywords: SARS-CoV-2, delta, omicron, Domestic cats, ex-vivo, Explant, Transcriptomic profiling

Received: 30 Dec 2024; Accepted: 11 Aug 2025.

Copyright: © 2025 Panwar, Raut, Bhatia, Pateriya, Kumar, Sood, Saran, Sehgal, J MOHAN, Zararia and Mishra. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Anamika Mishra, ICAR-National Institute of High Security Animal Diseases (ICAR-NIHSAD), Bhopal, India

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.